lapatinib has been researched along with gadolinium dtpa in 1 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 12,654 | 664 | 4,051 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arihiro, K; Awai, K; Date, S; Hirokawa, Y; Iida, M; Kakizawa, H; Kitamura, S; Nakamura, Y; Tatsugami, F; Yamasaki, W | 1 |
1 other study(ies) available for lapatinib and gadolinium dtpa
Article | Year |
---|---|
Effect of lapatinib on hepatic parenchymal enhancement on gadoxetate disodium (EOB)-enhanced MRI scans of the rat liver.
Topics: Animals; Antineoplastic Agents; Biomarkers; Contrast Media; Gadolinium DTPA; Gene Expression Regulation, Neoplastic; Image Enhancement; Lapatinib; Liver; Magnetic Resonance Imaging; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Cation Transport Proteins; Quinazolines; Rats | 2013 |